Top compounds associated with response to USP17L22


Feature Type Standardized
Nominal ANOVA
mRNA tivozanib CTRPv2 pan-cancer AAC -0.022 0.5
mRNA Vandetanib CTRPv2 pan-cancer AAC -0.021 0.5
mRNA Bax channel blocker CTRPv2 pan-cancer AAC -0.022 0.5
mRNA selumetinib:PLX-4032 (8:1 mol/mol) CTRPv2 pan-cancer AAC -0.021 0.5
mRNA tanespimycin:bortezomib (250:1 mol/mol) CTRPv2 pan-cancer AAC 0.022 0.6
mRNA LY-2157299 CTRPv2 pan-cancer AAC -0.043 0.6
mRNA erastin CTRPv2 pan-cancer AAC -0.02 0.6
mRNA RG-108 CTRPv2 pan-cancer AAC -0.021 0.6
mRNA JQ-1:carboplatin (1:1 mol/mol) CTRPv2 pan-cancer AAC -0.018 0.6
mRNA BRD-K30748066 CTRPv2 pan-cancer AAC 0.076 0.6
Download CSV